Latest Commercialization News

Dart Mining continues to reveal promising antimony mineralisation at its Coonambula project in Queensland, aligning with the new Australia-USA critical minerals pact. Assay results are pending, but visual drilling intercepts suggest significant potential.

CONNEQT Health reports robust sales momentum for its CONNEQT Pulse arterial health monitor, with quarterly sales growth exceeding 50% and a fresh order for 10,000 units to meet rising demand.

Iondrive Limited has inked a binding term sheet with LAT66 Limited to apply its innovative Deep Eutectic Solvent technology to cobalt-rich concentrates from Finland’s Kuusamo projects, marking a strategic step beyond battery recycling into primary mineral processing.

Neurizon Therapeutics has been granted a key Australian patent for its lead drug candidate NUZ-001, extending protection for treatments targeting ALS, Alzheimer's, and other neurodegenerative diseases through 2041. This milestone complements earlier US patent grants and sets the stage for upcoming clinical trials.

Nexsen Limited has initiated clinical trials for its StrepSure® GBS Rapid Sensor, a next-generation diagnostic device aimed at improving maternal health outcomes. The trial's success could pave the way for regulatory approval and early market penetration by the second half of 2026.

PMET Resources has completed a positive lithium-only feasibility study for its Shaakichiuwaanaan Project in Quebec, confirming technical and economic viability for a large-scale spodumene concentrate operation with a targeted final investment decision in 2027.

Aurelia Metals has kicked off FY26 with robust production and cost management, driven by the ahead-of-schedule ramp-up at its Federation mine and promising progress at Great Cobar.

Aurelia Metals reports a 12% increase in Mineral Resources and a 17% rise in Ore Reserves, driven by strong copper growth at its Peak Operation and the commencement of production at Federation Mine.

Anson Resources has initiated a re-entry drilling program at its Mt Fuel-Skyline Geyser well in Utah, aiming to convert exploration targets into JORC-compliant lithium resources by sampling deep lithium-rich brines.

Genetic Signatures Ltd reports a robust start to FY2026 with a 20% quarterly sales increase, driven by new US contracts and strong growth in EMEA and Australia. The company also bolsters its leadership with a new CTO appointment.

HUB24 has reported a record $5.2 billion in net inflows for Q1 FY26, boosting its Funds Under Administration to $146.5 billion and securing the top spot for adviser satisfaction in Australia.

West Cobar Metals has revealed that previous assays underestimated antimony grades at its Bulla Park deposit, with re-analysis showing an average 14% increase. This discovery could enhance the project's economics and resource potential.